Scientific/ASiT Session
AB080. 15. Insights into faecal incontinence among a healthy population in a tertiary referral centre
Mesentery and Peritoneum
2019;
3:
AB080
(22 February 2019)
Scientific/ASiT Session
AB079. 190. Computed tomography measured mesenteric adiposity is associated with diverticulitis
Mesentery and Peritoneum
2019;
3:
AB079
(22 February 2019)
Scientific/ASiT Session
AB078. 86. Ten years of inguinal lymphadenectomy for metastatic malignant melanoma: a single centre experience
Mesentery and Peritoneum
2019;
3:
AB078
(22 February 2019)
Scientific/ASiT Session
AB077. 174. Performance indicator of colonic intubation: a new key performance indicator for colonoscopies?
Mesentery and Peritoneum
2019;
3:
AB077
(22 February 2019)
Scientific/ASiT Session
AB076. 199. Enhancing anti-tumour immune response: the effect of Ionising radiation on Immune checkpoint expression in OE33 cells
Mesentery and Peritoneum
2019;
3:
AB076
(22 February 2019)
Scientific/ASiT Session
AB075. 242. Comprehensive evaluation of a novel biomarker and other biomarkers for appendicitis in adults
Mesentery and Peritoneum
2019;
3:
AB075
(22 February 2019)
Scientific/ASiT Session
AB074. 134. A trainee’s experience establishing a porcine ex-vivo lung perfusion model in Ireland
Mesentery and Peritoneum
2019;
3:
AB074
(22 February 2019)
Scientific/ASiT Session
AB073. 54. Serial cell free DNA (cfDNA) monitoring in melanoma patients correlates with tumour burden and therapeutic response as assessed by CT scan
Mesentery and Peritoneum
2019;
3:
AB073
(22 February 2019)
Scientific/ASiT Session
AB072. 103. Effectiveness of an admission proforma in improving prescription of thromboprophylaxis in acutely ill medical patients. Re-valuating current performance in University Hospital Limerick a decade later
Mesentery and Peritoneum
2019;
3:
AB072
(22 February 2019)
Scientific/ASiT Session
AB071. 136. Characteristics of the tumour microenvironment affect the expression of inhibitory immune checkpoints on T-cells and oesophageal adenocarcinoma cells
Mesentery and Peritoneum
2019;
3:
AB071
(22 February 2019)
Scientific/ASiT Session
AB070. 125. Evaluation of a hydrogel scaffold seeded with mature adipocytes for breast reconstruction post-mastectomy
Mesentery and Peritoneum
2019;
3:
AB070
(22 February 2019)
Plenary Session
AB069. 191. Establishing a surgical basecamp for undergraduates commencing clinical surgery module
Mesentery and Peritoneum
2019;
3:
AB069
(22 February 2019)
Plenary Session
AB068. 23. Implementation of a minimally invasive oesophagectomy programme: Results from 135 consecutive cases
Mesentery and Peritoneum
2019;
3:
AB068
(22 February 2019)
Plenary Session
AB067. 209. Unravelling the dysbiosis concept in ulcerative colitis
Mesentery and Peritoneum
2019;
3:
AB067
(22 February 2019)
Plenary Session
AB066. 208. Loss of estrogen receptor (ER) through DNA methylation and alterations in molecular heterogeneity during endocrine treatment in ER-positive breast cancer
Mesentery and Peritoneum
2019;
3:
AB066
(22 February 2019)
Plenary Session
AB065. 137. Clinically relevant chemotherapies promote immune resistance via upregulation of inhibitory immune checkpoints on T-cells and oesophageal adenocarcinoma cells
Mesentery and Peritoneum
2019;
3:
AB065
(22 February 2019)
Plenary Session
AB064. 127. Evaluating the suitability and oncological safety of autologous breast cancer patient derived adipose derived stem cells for use in breast regeneration
Mesentery and Peritoneum
2019;
3:
AB064
(22 February 2019)
Plenary Session
AB063. 82. Development of a porcine urethral model to characterize the effect of catheter balloon injury on the paediatric urethra
Mesentery and Peritoneum
2019;
3:
AB063
(22 February 2019)
Plenary Session
AB062. 234. Activation of an orphan nuclear receptor type 4A1 (NR4A1) represses pro-tumourogenic mediators in colorectal cancer
Mesentery and Peritoneum
2019;
3:
AB062
(22 February 2019)
Plenary Session
AB061. 211. A comparison of single-stage versus two-stage resections for colorectal liver metastases
Mesentery and Peritoneum
2019;
3:
AB061
(22 February 2019)
Plenary Session
AB060. 207. Digital reconstruction of human mesentery development
Mesentery and Peritoneum
2019;
3:
AB060
(22 February 2019)
Plenary Session
AB059. 188. The effect of extending the interval between the end of long-course chemoradiation and total mesorectal excision on pathological, surgical and oncologic outcomes in patients with rectal cancer: a systematic review and meta-analysis
Mesentery and Peritoneum
2019;
3:
AB059
(22 February 2019)
Plenary Session
AB058. 126. Observing peri-operative cell-free DNA dynamics may enable identification of patients at risk of early recurrence in colon cancer
Mesentery and Peritoneum
2019;
3:
AB058
(22 February 2019)
Plenary Session
AB057. 33. Post-operative pain following laparoscopic right hemicolectomy for Crohn’s disease: a comparative study
Mesentery and Peritoneum
2019;
3:
AB057
(22 February 2019)
Upper GI/Hepatobiliary Session
AB056. 206. Transitioning to totally minimally invasive esophagectomy: what are the peri-operative benefits?
Mesentery and Peritoneum
2019;
3:
AB056
(22 February 2019)
Upper GI/Hepatobiliary Session
AB055. 214. Management of cholangiocarcinoma: the national experience
Mesentery and Peritoneum
2019;
3:
AB055
(22 February 2019)
Upper GI/Hepatobiliary Session
AB054. 117. Clinical classification and severity scoring systems in chronic pancreatitis: a systematic review
Mesentery and Peritoneum
2019;
3:
AB054
(22 February 2019)
Upper GI/Hepatobiliary Session
AB053. 116. Long-term outcome of chronic pancreatitis, in-depth evaluation of a complex disease
Mesentery and Peritoneum
2019;
3:
AB053
(22 February 2019)
Upper GI/Hepatobiliary Session
AB052. 115. “Trinity CP Score” objective, reliable and efficient scoring system for use in clinical setting for standardisation of chronic pancreatitis
Mesentery and Peritoneum
2019;
3:
AB052
(22 February 2019)
Upper GI/Hepatobiliary Session
AB051. 64. Correlation between endoscopic and histopathological findings in gastritis
Mesentery and Peritoneum
2019;
3:
AB051
(22 February 2019)